Berlin - Delayed Quote EUR
Bone Therapeutics SA (BT1.BE)
0.0020
0.0000
(0.00%)
As of April 4 at 8:11:43 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
1,000
Operating Expense
7,040
7,040
2,319
878
16,017
Operating Income
-7,040
-7,040
-2,319
-878
-15,017
Net Non Operating Interest Income Expense
-2,716
-2,716
-286
-107
-723
Pretax Income
-29,028
-29,028
-3,049
-984
-15,754
Tax Provision
-7
-7
--
--
78
Net Income Common Stockholders
-28,778
-28,778
-2,041
-984
-11,940
Diluted NI Available to Com Stockholders
-28,778
-28,778
-2,041
-984
-11,940
Basic EPS
-0.21
--
-0.02
-14.89
-1.02
Diluted EPS
-0.21
--
-0.02
-14.89
-1.02
Basic Average Shares
136,932.0180
--
120,132.0130
66.3890
11,723.1820
Diluted Average Shares
136,932.0180
--
120,132.0130
66.3890
11,723.1820
Total Operating Income as Reported
-7,040
-7,040
-2,318
-877
-15,017
Rent Expense Supplemental
259
259
10
--
--
Total Expenses
7,040
7,040
2,319
878
16,017
Net Income from Continuing & Discontinued Operation
-28,778
-28,778
-2,041
-984
-11,940
Normalized Income
-9,508.6479
-9,508.6479
-1,596
-984
-15,831
Interest Income
57
57
3
--
24
Interest Expense
1,519
1,519
278
62
678
Net Interest Income
-2,716
-2,716
-286
-107
-723
EBIT
-27,509
-27,509
-2,771
-922
-15,076
EBITDA
-27,266
-27,266
-2,711
-909
-14,475
Reconciled Depreciation
243
243
60
13
601
Net Income from Continuing Operation Net Minority Interest
-28,778
-28,778
-2,041
-984
-15,831
Total Unusual Items Excluding Goodwill
-19,274
-19,274
-445
--
--
Total Unusual Items
-19,274
-19,274
-445
--
--
Normalized EBITDA
-7,992
-7,992
-2,266
-909
-14,475
Tax Rate for Calcs
0
0
--
--
0.0003
Tax Effect of Unusual Items
-4.6479
-4.6479
--
--
--
12/31/2020 - 8/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9TD.F Arctic Bioscience AS
0.3790
+8.29%
IMM.L ImmuPharma plc
2.4248
-0.01%
ALCLS.PA Cellectis S.A.
1.3880
+0.58%
SANN.SW Santhera Pharmaceuticals Holding AG
14.98
+0.94%
INTS Intensity Therapeutics, Inc.
0.5658
-37.14%
TLX.AX Telix Pharmaceuticals Limited
26.68
-6.58%
MESO Mesoblast Limited
11.82
-0.34%
AKESF Akeso, Inc.
13.59
+1.42%
IBRX ImmunityBio, Inc.
2.6100
-2.97%
SMMT Summit Therapeutics Inc.
23.47
-36.06%